Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies
出版年份 2012 全文链接
标题
Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies
作者
关键词
-
出版物
Immunotherapy
Volume 4, Issue 2, Pages 213-238
出版商
Future Medicine Ltd
发表日期
2012-02-17
DOI
10.2217/imt.11.170
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Is Tau Aggregation Toxic or Protective?
- (2017) Erin E. Congdon et al. JOURNAL OF ALZHEIMERS DISEASE
- Chaperone-like Antibodies Targeting Misfolded Tau Protein: New Vistas in the Immunotherapy of Neurodegenerative Foldopathies
- (2017) Norbert Zilka et al. JOURNAL OF ALZHEIMERS DISEASE
- Increase of BDNF Serum Concentration in Lithium Treated Patients with Early Alzheimer's Disease
- (2017) Thomas Leyhe et al. JOURNAL OF ALZHEIMERS DISEASE
- Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β
- (2017) Rudy J. Castellani et al. JOURNAL OF ALZHEIMERS DISEASE
- PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
- (2017) Noel G. Faux et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid Imaging in Aging and Dementia: Testing the Amyloid HypothesisIn Vivo
- (2014) G. D. Rabinovici et al. BEHAVIOURAL NEUROLOGY
- Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
- (2012) David H. Cribbs CNS & Neurological Disorders-Drug Targets
- EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
- (2012) B. Vellas et al. Current Alzheimer Research
- Stopping a thief and killer: Alzheimer's disease crisis demands greater commitment to research
- (2011) William Thies Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Tau Oligomers as Potential Targets for Immunotherapy for Alzheimers Disease and Tauopathies
- (2011) C. A. Lasagna-Reeves et al. Current Alzheimer Research
- Anti-β-Amyloid Immunotherapy for Alzheimers Disease: Focus on Bapineuzumab
- (2011) Francesco Panza et al. Current Alzheimer Research
- Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads
- (2011) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Solanezumab for Alzheimer's disease
- (2011) Hossein Samadi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antibody-based therapy in Alzheimer's disease
- (2011) Refik Pul et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?
- (2011) Bruno P Imbimbo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Anti-tau oligomers passive vaccination for the treatment of Alzheimer disease
- (2011) Rakez Kayed Human vaccines & immunotherapeutics
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Chronic Intranasal Treatment with an Anti-Aβ30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
- (2011) Susann Cattepoel et al. PLoS One
- A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
- (2010) Ronald S. Black et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Immunotherapy with bapineuzumab lowers CSF tau protein levels in patients with Alzheimer's disease
- (2010) Kaj Blennow et al. Alzheimers & Dementia
- The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
- (2010) Michael W. Weiner et al. Alzheimers & Dementia
- Murine models of Alzheimer's disease and their use in developing immunotherapies
- (2010) Thomas Wisniewski et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- TAU Aggregation is a Therapeutic Target for Alzheimers Disease
- (2010) A. Takashima Current Alzheimer Research
- Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid
- (2010) V. Frisardi et al. Current Alzheimer Research
- Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
- (2010) Moran Boimel et al. EXPERIMENTAL NEUROLOGY
- Bapineuzumab
- (2010) Geoffrey A Kerchner et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Current therapeutic targets for the treatment of Alzheimer’s disease
- (2010) Joshua D Grill et al. Expert Review of Neurotherapeutics
- Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease
- (2010) Francesco Panza et al. Immunotherapy
- Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss
- (2010) Tetsuya Kimura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
- (2010) John C O'Leary et al. Molecular Neurodegeneration
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?
- (2010) Cynthia A. Lemere et al. Nature Reviews Neurology
- Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease
- (2010) Chiou-Miin Wang et al. NEUROBIOLOGY OF DISEASE
- Tau protein and tau aggregation inhibitors
- (2010) Bruno Bulic et al. NEUROPHARMACOLOGY
- T Cells Specifically Targeted to Amyloid Plaques Enhance Plaque Clearance in a Mouse Model of Alzheimer's Disease
- (2010) Yair Fisher et al. PLoS One
- Immunization Therapy for Alzheimer Disease: A Comprehensive Review of Active Immunization Strategies
- (2010) Takeshi Tabira TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanisms of tau-induced neurodegeneration
- (2009) Khalid Iqbal et al. ACTA NEUROPATHOLOGICA
- Immunotherapy targeting Alzheimer's phospho-tau epitope within the microtubule binding region of tau clears pathological tau and prevents functional decline in a mouse model of tauopathy
- (2009) Pavan K. Krishnamurthy et al. Alzheimers & Dementia
- Identification, characterization, and comparison of amino-terminally truncated Aβ 42 peptides in Alzheimer's disease brain tissue and in plasma from Alzheimer's patients receiving solanezumab immunotherapy treatment
- (2009) Ronald B. DeMattos et al. Alzheimers & Dementia
- Selection of an anti-Abeta antibody that binds various forms of Abeta and blocks toxicity both in vitro and in vivo
- (2009) Ryan J. Watts et al. Alzheimers & Dementia
- Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy
- (2009) Michal Novak Alzheimers & Dementia
- Preliminary population pharmacokinetic modeling of PF-04360365, a humanized anti-amyloid monoclonal antibody, in patients with mild-to-moderate Alzheimer's disease
- (2009) Timothy Nicholas et al. Alzheimers & Dementia
- The ADCS valproate neuroprotection trial: Primary efficacy and safety results
- (2009) Pierre N. Tariot et al. Alzheimers & Dementia
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening
- (2009) Alex Crowe et al. BIOCHEMISTRY
- Chaperone-Like Antibodies in Neurodegenerative Tauopathies: Implication for Immunotherapy
- (2009) Eva Kontsekova et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
- (2009) Rakez Kayed et al. CURRENT OPINION IN IMMUNOLOGY
- Disease-Modifying Approach to the Treatment of Alzheimerʼs Disease
- (2009) Francesco Panza et al. DRUGS & AGING
- Targeting Aβ and tau in Alzheimer's disease, an early interim report
- (2009) Todd E. Golde et al. EXPERIMENTAL NEUROLOGY
- Is passive immunization for Alzheimer's disease ‘alive and well’ or ‘dead and buried’?
- (2009) Gregory A Jicha EXPERT OPINION ON BIOLOGICAL THERAPY
- Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
- (2009) Pierre N. Tariot et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Vaccination with A -Displaying Virus-Like Particles Reduces Soluble and Insoluble Cerebral A and Lowers Plaque Burden in APP Transgenic Mice
- (2009) P. Bach et al. JOURNAL OF IMMUNOLOGY
- Tau oligomers and aggregation in Alzheimer’s disease
- (2009) Marco A. Meraz-Ríos et al. JOURNAL OF NEUROCHEMISTRY
- Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy
- (2009) Alix de Calignon et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- A Immunotherapy: Intracerebral Sequestration of A by an Anti-A Monoclonal Antibody 266 with High Affinity to Soluble A
- (2009) K. Yamada et al. JOURNAL OF NEUROSCIENCE
- Intrabody Gene Therapy Ameliorates Motor, Cognitive, and Neuropathological Symptoms in Multiple Mouse Models of Huntington's Disease
- (2009) A. L. Southwell et al. JOURNAL OF NEUROSCIENCE
- Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
- (2009) C. Wischik et al. Journal of Nutrition Health & Aging
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
- (2009) Kurt R. Brunden et al. NATURE REVIEWS DRUG DISCOVERY
- IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders
- (2009) H. Fillit et al. NEUROLOGY
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- The Role of Apolipoprotein E in Alzheimer's Disease
- (2009) Jungsu Kim et al. NEURON
- Oligomeric amyloid associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
- (2009) R. M. Koffie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease
- (2009) M. Britschgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel therapeutic strategies for neurodegenerative disease
- (2009) Hitoshi TANIMUKAI et al. Psychogeriatrics
- O4-01-05: Presenilin 1 mutation promotes Tau phosphorylation and aggregation in a novel Alzheimer's disease mouse model
- (2008) Allal Boutajangout et al. Alzheimers & Dementia
- O4-04-04: Tau immunotherapy prevents cognitive decline and clears pathological Tau in a tangle mouse model
- (2008) Einar M. Sigurdsson et al. Alzheimers & Dementia
- S1-02-02: Natural human antibodies targeting amyloid aggregates in intravenous immunoglobulin
- (2008) Norman R. Relkin Alzheimers & Dementia
- P4-347: Tau aggregation inhibitor (TAI) therapy with rember™ arrests the trajectory of rCBF decline in brain regions affected by Tau pathology in mild and moderate Alzheimer's disease (AD)
- (2008) Roger T. Staff et al. Alzheimers & Dementia
- P4-346: Safety, tolerability and biomarker effects of an Abeta monoclonal antibody administered to patients with Alzheimer's disease
- (2008) Eric R. Siemers et al. Alzheimers & Dementia
- P4-384: Tau Aggregation Inhibitor (TAI) therapy with rember™ changes glucose metabolism in the medial temporal lobes in mild and moderate Alzheimer's disease (AD)
- (2008) Alison D. Murray et al. Alzheimers & Dementia
- O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
- (2008) Claude M. Wischik et al. Alzheimers & Dementia
- A nasal proteosome adjuvant activates microglia and prevents amyloid deposition
- (2008) Dan Frenkel et al. ANNALS OF NEUROLOGY
- Active and Passive Immunotherapy for Neurodegenerative Disorders
- (2008) David L. Brody et al. Annual Review of Neuroscience
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
- (2008) Dennis J. Selkoe BEHAVIOURAL BRAIN RESEARCH
- Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain
- (2008) D. Boche et al. BRAIN
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
- A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics
- (2008) Hanna Rosenmann et al. EXPERIMENTAL NEUROLOGY
- Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice
- (2008) S. Schroeter et al. JOURNAL OF NEUROSCIENCE
- Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3 Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing
- (2008) Y. Wen et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Amyloid-β immunisation for Alzheimer's disease
- (2008) Thomas Wisniewski et al. LANCET NEUROLOGY
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Animal models of Alzheimer's disease and frontotemporal dementia
- (2008) Jürgen Götz et al. NATURE REVIEWS NEUROSCIENCE
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse
- (2008) Peter Seubert et al. Neurodegenerative Diseases
- Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated Meningoencephalitis
- (2008) Michael Pride et al. Neurodegenerative Diseases
- Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
- (2008) Scott A. Small et al. NEURON
- Tau-based treatment strategies in neurodegenerative diseases
- (2008) Anja Schneider et al. Neurotherapeutics
- Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy
- (2008) Nina Movsesyan et al. PLoS One
- Antibody-based approaches in Alzheimer’s research: safety, pharmacokinetics, metabolism, and analytical tools
- (2007) Peter Lichtlen et al. JOURNAL OF NEUROCHEMISTRY
- Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide
- (2003) Merav Bassan et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started